Toronto Dominion Bank Royalty Pharma PLC Transaction History

Toronto Dominion Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $57,036 - $64,942	2,172 Added 5.23%	43,714 $1.15 Million
Q1 2024 May 14, 2024	SELL	$27.46 - $31.33 $367,634 - $419,446	-13,388 Reduced 24.37%	41,542 $1.26 Million
Q4 2023 Feb 13, 2024	SELL	$26.21 - $29.22 $1.26 Million - $1.4 Million	-48,061 Reduced 46.67%	54,930 $1.54 Million
Q3 2023 Feb 14, 2024	BUY	$26.26 - $31.38 $1.26 Million - $1.51 Million	48,061 Added 87.49%	102,991 $2.8 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $2.7 Million - $3.23 Million	102,991 New	102,991 $2.8 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.